Home/Filings/4/0001178913-22-001020
4//SEC Filing

Moses Alan Charles 4

Accession 0001178913-22-001020

CIK 0001534248other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 4:04 PM ET

Size

8.3 KB

Accession

0001178913-22-001020

Insider Transaction Report

Form 4
Period: 2022-03-07
Transactions
  • Award

    Option to Purchase American Depositary Shares

    2022-03-07+6,8206,820 total
    Exercise: $3.53Exp: 2032-03-07American Depositary Shares (6,820 underlying)
  • Award

    Option to Purchase American Depositary Shares

    2021-04-19+11,88411,884 total
    Exercise: $27.26Exp: 2031-04-19American Depositary Shares (11,884 underlying)
Footnotes (4)
  • [F1]These options vest and become exercisable in their entirety on March 16, 2023.
  • [F2]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
  • [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  • [F4]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.

Documents

1 file

Issuer

Chemomab Therapeutics Ltd.

CIK 0001534248

Entity typeother

Related Parties

1
  • filerCIK 0001819501

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:04 PM ET
Size
8.3 KB